Busy. Please wait.
or

show password
Forgot Password?

Don't have an account?  Sign up 
or

Username is available taken
show password

why


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
We do not share your email address with others. It is only used to allow you to reset your password. For details read our Privacy Policy and Terms of Service.


Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.
Don't know
Know
remaining cards
Save
0:01
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
Retries:
restart all cards
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

DEFINITIONS--SOCRA19

CCRP/SOCRA

TermDefinition
21 CFR PART 11 ELECTRONIC RECORDS AND ELECTRONIC SIGNATURES
21 CFR PART 50 PROTECTION OF HUMAN SUBJECTS
21 CFR PART 56 INSTITUTIONAL REVIEW BOARD (IRB)
21 CFR PART 312 INVESTIGATIONAL NEW DRUG APPLICATION (IND)
21 CFR PART 812 INVESTIGATIONAL DEVICE EXEMPTIONS (IDE)
45 CFR PART 46 SUBPART A BASIC HHS POLICY FOR PROTECTION OF HUMAN RESEARCH SUBJECTS
45 CFR PART 46 SUBPART B ADDITIONAL PROTECTIONS FOR PREGNANT WOMEN, HUMAN FETUSES AND NEONATES INVOLVED IN RESEARCH
45 CFR PART 46 SUBPART C ADDITIONAL PROTECTIONS PERTAINING TO BIOMEDICAL AND BEHAVIORAL RESEARCH INVOLVING PRISONERS AS SUBJECTS
45 CFR PART 46 SUBPART D ADDITIONAL PROTECTIONS FOR CHILDREN INVOLVED AS SUBJECTS IN RESEARCH
45 CFR PART 46 SUBPART E REGISTRATION OF INSTITUTIONAL REVIEW BOARDS
FDA FORM 482 NOTICE OF FDA INSPECTION
FDA FORM 483 INSPECTIONAL FDA OBSERVATIONS
FDA FORM 1572 STATEMENT OF INVESTIGATOR
FDA FORM 3454 CERTIFICATION- FINANCIAL INTERESTS AND ARRANGEMENTS OF CLINICAL INVESTIGATORS
FDA FORM 3455 DISCLOSURE- FINANCIAL INTERESTS AND ARRANGEMENTS OF CLINICAL INVESTIGATORS
FDA FORM 3500 VOLUNTARY REPORTING OF ADVERSE EVENTS AND PRODUCT PROBLEMS
FDA FORM 3500A FOR USE BY USER-FACILITIES, DISTRIBUTORS, AND MANUFACTURERS FOR MANDATORY REPORTING
THE BELMONT REPORT THIS REPORT DESCRIBES ETHICAL PRINCIPLES AND GUIDELINES FOR THE PROTECTION OF HUMAN SUBJECTS. IT WAS CREATED BY THE NATIONAL COMMISION FOR THE PROTECTION OF HUMAN SUBJECTS OF BIOMEDICAL AND BEHAVIORAL RESEARCH ON APRIL 18, 1979
THE BELMON REPORT; PART A BOUNDARIES BETWEEN PRACTICE AND RESEARCH
THE BELMON REPORT; PART B BASIC ETHICAL PRINCIPLES
THE BELMON REPORT; PART C APPLICATIONS
THE NUREMBERG CODE THE NUREMBERG CODE IS A SET OF ETHICAL PRINCIPLES FOR HUMAN EXPERIMENTATION DEVELOPED IN 1947.
THE DECLARATION OF HELSINKI THE DECLARATION, ORIGINALLY ADOPTED IN JUNE OF 1964, IS A SET OF ETHICAL PRINCIPLES FOR MEDICAL RESEARCH INVOLVING HUMAN SUBJECTS. IT HAS BEEN AMENDED A NUMBER OF TIMES SINCE THE ORIGINAL ADOPTION.
GOOD CLINICAL PRACTICE GOOD CLINICAL PRACTICE (GCP) IS AN INTERNATIONAL ETHICAL AND SCIENTIFIC QUALITY STANDARD FOR DESIGNING, CONDUCTING, RECORDING AND REPORTING TRIALS THAT INVOLVE PARTICIPATION OF HUMAN SUBJECTS.
ADVERSE EVENT ANY UNTOWARD MEDICAL OCCURRENCE IN A PATIENT OR CLINICAL INVESTIGATION SUBJECT ADMINISTERED A PHARMACEUTICAL PRODUCT AND WHICH DOES NOT NECESSARILY HAVE TO HAVE A CAUSAL RELATIONSHIP WITH THIS TREATMENT.
ADVERSE DRUG REACTION (ADR) IN PRE-APPROVAL CLINICAL EXPERIENCE: ALL NOXIOUS AND UNINTENDED RESPONSES TO A MEDICINAL PRODUCT RELATED TO ANY DOSE SHOULD BE CONSIDERED ADVERSE DRUG REACTIONS.
ADVERSE DRUG REACTION (ADR) IN MARKETED MEDICINAL PRODUCTS: A RESPONSE TO A DRUG WHICH IS NOXIOUS AND UNINTENDED AND WHICH OCCURS AT DOSES NORMALLY USED IN MAN FOR PROPHYLAXIS, DIAGNOSIS, OR THERAPY OF DISEASE OR FOR MODIFICATION OF PHYSIOLOGICAL FUNCTION.
UNEXPECTED ADVERSE DRUG REACTION AN ADVERSE REACTION, THE NATURE OR SEVERITY OF WHICH IS NOT CONSISTENT WITH THE APPLICABLE PRODUCT INFORMATION
Created by: kendraskye1